Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.


Type 1 Diabetes

(Insulin Dependent Diabetes Mellitus; Juvenile-Onset Diabetes; Ketosis-Prone Diabetes; "Brittle" Diabetes; Diabetes Mellitus Type 1; Diabetes, Type 1)
Definition

Type 1 diabetes is when the body does not make enough insulin. Insulin is a hormone that helps your body convert food into energy. Without insulin, glucose (sugar) from the food you eat cannot enter cells. So glucose builds up in the blood. Your body tissue becomes starved for energy.

Type 1 diabetes usually begins in children and young adults. Over the long-term, if type 1 diabetes is not adequately treated, high blood sugar levels can damage the blood vessels, heart, kidneys, eyes, nerves, and other tissues or organs.

Causes

Most cases of type 1 diabetes are caused by the body's immune system attacking and destroying the islet cells that make insulin. These cells are in the pancreas. The current theory is that some people have genes that make them prone to getting type 1 diabetes. For these people, certain things in the environment may trigger an immune system attack on the pancreas. The trigger or triggers have yet to be identified, but may be certain viruses, foods, or chemicals.

Risk Factors

Risk factors include:

  • Other autoimmune illness, including:
  • Age: starts at age 4 with peak at ages 11-13
  • Bottle-feeding or short duration of breastfeeding
  • Ethnicity: Northern European, Mediterranean, African Americans, Hispanics
  • Family history (parent, sibling) of type 1 diabetes
  • Obesity during childhood
  • Risk increases with increase in birth weight
  • Sex: more common in males than females
Symptoms

If you have any of these symptoms, do not assume it is due to type 1 diabetes. These symptoms may be caused by other conditions. Tell your doctor if you have any of these:

  • Blurry vision
  • Extreme thirst
  • Fatigue, weakness
  • Headaches
  • Hunger
  • Increased urination
  • Irritability
  • Weight loss

Destruction of insulin-producing pancreatic cells may occur so quickly that ketoacidosis (commonly known as diabetic coma) is the first sign of a problem. Symptoms of ketoacidosis include:

  • Abdominal pain
  • Abnormally deep and fast breathing
  • Coma
  • Dehydration (not enough fluid in the body)
  • Drowsiness
  • Dry skin and mouth
  • Fruity breath odor
  • Low blood pressure
  • Rapid pulse
  • Vomiting and nausea
Diagnosis

The doctor will ask about your symptoms, medical history, and family history, and do a physical exam.

Type 1 diabetes is diagnosed based on the results of blood tests and other criteria. These include:

  • Blood sugar tests after you have not eaten for eight or more hours (called fasting blood test) revealing blood sugar levels greater than or equal to 126 mg/dL (7.0 mmol/L) on two different days
  • Glucose tolerance test measuring blood sugar two hours after you consume glucose with a measurement greater than or equal to 200 mg/dL (11.1 mmol/L)
  • HbA1c level of 6.5% or higher, indicating high blood sugar over the past 2-4 months
  • Symptoms consistent with diabetes and a random blood test revealing a blood sugar level greater than or equal to 200 mg/dL* (11.1 mmol/L)

*mg/dL = milligrams per deciliter of blood, mmol/L = millimole per liter of blood

Some children may be tested for insulin levels or anti-islet cell antibodies to confirm the diagnosis.

Treatment

Diabetes treatment aims to maintain blood sugar at levels as close to normal as possible. Regular medical care is important for preventing or delaying complications.

Insulin

Insulin injection replaces the natural insulin the pancreas would normally produce. The dosage is adjusted based on results of blood sugar tests before and after meals and at bedtime. You will need to have insulin shots two, three, or more times daily. Or you may wear an insulin pump that continually gives you a small amount of insulin. The pump connects to tubing and a small needle or catheter under the skin.

Pramlintide

Amylin is made in the pancreas along with insulin. In people with type 1 diabetes, this hormone is lacking, also like insulin. Researchers think that the post-meal glucose rise in people with diabetes is somehow related to the amylin deficiency. The drug pramlintide (Symlin) may be used when insulin therapy is insufficient to adequately control blood sugar.

Diet

If you have type 1 diabetes, you should meet regularly with a registered dietician. Generally speaking, it is best to:

  • Avoid highly refined carbohydrates (sugar or high fructose products).
  • Eat consistently at regular times each day, including a bedtime snack.
  • Follow a well-balanced meal plan incorporating a variety of food groups.
Exercise

Exercise is encouraged when blood sugar levels are consistently under control and there are no complications. Follow your doctor's advice on activity levels and restrictions. You may need to adjust your insulin regimen or diet to compensate for low glucose levels linked to exercise.

Blood Sugar Testing

Checking blood sugar levels during the day helps you track the amount of glucose in your blood. Testing is easy with a blood glucose monitor. You can also ask your doctor about continuous glucose monitoring systems that you wear all day.

Keep a record of the results to show your doctor. Your treatment plan may change based on your test results. The HbA1c blood test is also used by your doctor to access your overall diabetes control.

Pancreatic Islet Cell Transplant

This is an experimental procedure. It involves transplanting islet cells from a donor to a person with type 1 diabetes. After the transplant, these new cells are able to produce insulin. In some cases, people who receive these transplants may no longer need insulin injections.

Closed-Loop Artificial Pancreas

This device, which is still being studied, automatically checks glucose levels using a continuous glucose monitoring system (CGMS). Insulin is delivered as needed throughout the day and night. It will allow you to keep your blood sugar levels within the normal range without having to do daily blood sugar testing and injections. Scientists have also designed the device to deliver glucagon, a hormone that can work to prevent hypoglycemia.

Pancreatic Transplant

This procedure is recommended if you have:

  • Severe kidney disease and need a kidney transplant at the same time as the pancreatic transplant
  • Acute diabetic complications or emergencies not preventable by insulin
  • Severe and frequent diabetic complications
  • Severe problems due to injecting large amounts of insulin

If you are diagnosed with type 1 diabetes, follow your doctor's instructions .

Prevention

Currently, there is no known way to prevent type 1 diabetes. Researchers are studying immunosuppressive treatments that may benefit high-risk people.

Last reviewed: September 2011 by Lawrence Frisch, MD, MPH.

RESOURCES:
CANADIAN RESOURCES:
References:
  • American Association of Clinical Endocrinologists. American College of Endocrinology. Medical guidelines for the clinical practice for the management of diabetes mellitus. Endocrine Pract . 2007;13(suppl 1)3-68.
  • American Association of Clinical Endocrinologists. American College of Endocrinology. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management. 2002 update. Endocrine Pract . 2002;8(suppl 1)S40-82.
  • The DCCT/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 2 diabetes four years after a trial of intensive therapy. N Engl J Med . 2000;342:381-389.
  • Diabetes. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/nccdphp/publications/aag/ddt.htm . Updated February 14, 2008. Accessed July 21, 2008.
  • Diabetes mellitus type 1. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated January 2010. Accessed February 23, 2010.
  • DynaMed Editorial Team. Type 1 diabetes. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated July 15, 2010. Accessed August 4, 2010.
  • Health Day News. Artificial pancreas for type 1 diabetes moves closer to reality. EBSCO Health Library, Health Day News website. Available at: http://www.ebscohost.com/healthLibrary/ . Published April 2010. Accessed August 4, 2010.
  • Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet . 2008;371:117-125.
  • McMahon GT, Arky RA. Inhaled insulin for diabetes mellitus. N Engl J Med . 2007;356:497-502.
  • McQueen J. Pramlintide acetate. Am J Heal Pharm . 2005;62:2263-2272.
  • Nutrition principles and recommendations in diabetes. Diabetes Care . 2004;27(suppl 1)S36-46.
  • Pancreas transplantation in type 2 diabetes. Diabetes Care . 2004;27:S105.
  • Paviakis M, Khwaja K. Pancrease and islet cell transplantation in diabetes. Curr Opin Endocrinol Diabetes Obes . 2007;14:146-150.
  • Physical activity/exercise and diabetes. Diabetes Care . 2004;27(suppl 1)S58-62.
  • Scheid DC, McCarthy LH, Lawler FH, et al. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence. J Fam Pract . 2001;50:661-668.
  • Traina AN, Kane MP. Primer on pramlintide, an amylin analog. Diabetes Educ. 2011;37(3):426-431.
  • Type 1 diabetes. American Diabetes Association website. Available at: http://www.diabetes.org/type-1-diabetes.jsp . Accessed July 22, 2008.
  • 9/23/2008 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php : The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Sep 8. [Epub ahead of print]
  • 3/12/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php : Cardwell CR, Stene LC, Joner G, et al. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia. 2010 Jan 10. [Epub ahead of print]
  • 4/1/2011 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Verbeeten KC, Elks CE, Daneman D, Ong KK. Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med. 2011;28(1):10-18.